K080766

Substantially Equivalent

VIDAS RUB IGG

Applicant: bioMerieux, Inc.
Product code: LFX
Advisory panel: Microbiology
Date received: 2008-03-18
Decision date: 2008-12-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hazelwood, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.